Soligenix, Inc. – NASDAQ:SNGX
Soligenix stock price today
$3.68
+0.79
+27.34%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 6 hours
Soligenix stock price monthly change
-61.10%
month
Soligenix stock price quarterly change
-61.10%
quarter
Soligenix stock price yearly change
+351.49%
year
Soligenix key metrics
Market Cap | 7.27M |
Enterprise value | 1.33M |
P/E | -0.37 |
EV/Sales | 1.08 |
EV/EBITDA | -0.06 |
Price/Sales | 3.62 |
Price/Book | -1.80 |
PEG ratio | N/A |
EPS | -0.74 |
Revenue | 699.21K |
EBITDA | -8.02M |
Income | -7.00M |
Revenue Q/Q | -54.49% |
Revenue Y/Y | -31.31% |
Profit margin | -1860.94% |
Oper. margin | -1778.89% |
Gross margin | 31.87% |
EBIT margin | -1778.89% |
EBITDA margin | -1147.46% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeSoligenix stock price history
Soligenix stock forecast
Soligenix financial statements
| Jun 2023 | 206.92K | -1.61M | -779.02% |
|---|---|---|---|
| Sep 2023 | 130.44K | -1.66M | -1274.69% |
| Dec 2023 | 244.81K | -1.81M | -743.38% |
| Mar 2024 | 117.02K | -1.91M | -1636.63% |
| Dec 2023 | 244.81K | -1.81M | -743.38% |
|---|---|---|---|
| Mar 2024 | 117.02K | -1.91M | -1636.63% |
| Oct 2025 | 72.04K | -20.20M | -28038.71% |
| Dec 2025 | 66.45K | -20.20M | -30399.95% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 13826253 | 8.02M | 58.05% |
|---|---|---|---|
| Sep 2023 | 11302829 | 7.08M | 62.65% |
| Dec 2023 | 9797326 | 7.27M | 74.25% |
| Mar 2024 | 8058384 | 7.29M | 90.46% |
| Jun 2023 | -1.92M | 0 | 4.81M |
|---|---|---|---|
| Sep 2023 | -2.68M | 1.19M | -175.27K |
| Dec 2023 | -1.82M | -1.19M | -46.18K |
| Mar 2024 | -1.34M | 0 | -8.99K |
Soligenix alternative data
| Aug 2023 | 13 |
|---|---|
| Sep 2023 | 13 |
| Oct 2023 | 13 |
| Nov 2023 | 13 |
| Dec 2023 | 13 |
| Jan 2024 | 13 |
| Feb 2024 | 13 |
| Mar 2024 | 13 |
| Apr 2024 | 13 |
| May 2024 | 13 |
| Jun 2024 | 13 |
| Jul 2024 | 13 |
Soligenix other data
10.05%
+2.86%
of SNGX is owned by hedge funds
11
-20
19.24K
-187.32K
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Dec 2021 | 28000 | 0 |
| May 2022 | 28000 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | SCHABER CHRISTOPHER J director, officer.. | Common Stock | 20,000 | $0.44 | $8,860 | ||
Purchase | STRAUBE RICHARD officer: SENIOR V.. | COMMON STOCK | 8,000 | $0.5 | $4,000 | ||
Purchase | SCHABER CHRISTOPHER J director, officer.. | COMMON STOCK | 7,000 | $0.74 | $5,180 | ||
Purchase | GUARINO JONATHAN L. officer: Senior Vice President .. | COMMON STOCK | 1,000 | $0.7 | $700 | ||
Purchase | GUARINO JONATHAN L. officer: Senior Vice President .. | COMMON STOCK | 10,000 | $0.71 | $7,120 | ||
Purchase | SCHABER CHRISTOPHER J director, officer.. | COMMON STOCK | 10,000 | $0.73 | $7,270 | ||
Sale | ZELDIS JEROME B director | Common Stock | 3,000 | $0.9 | $2,700 | ||
Purchase | ZELDIS JEROME B director | Common Stock | 3,000 | $0.89 | $2,664 | ||
Purchase | SCHABER CHRISTOPHER J director, officer.. | Common Stock | 10,770 | N/A | N/A | ||
Purchase | ZELDIS JEROME B director | Common Stock | 2,000 | N/A | N/A |
| Patent |
|---|
Grant Filling date: 20 May 2020 Issue date: 6 Sep 2022 |
Grant Filling date: 9 Apr 2019 Issue date: 26 Apr 2022 |
Application Filling date: 10 May 2021 Issue date: 25 Nov 2021 |
Application Filling date: 20 May 2020 Issue date: 3 Dec 2020 |
Application Filling date: 9 Apr 2019 Issue date: 15 Oct 2020 |
Application Filling date: 21 Jun 2019 Issue date: 21 May 2020 |
| Insider | Compensation |
|---|---|
| Dr. Christopher J. Schaber Ph.D. (1966) Chairman, Chief Executive Officer & Pres | $810,300 |
| Dr. Oreola Donini Ph.D. (1972) Senior Vice President & Chief Scientific Officer | $380,460 |
| Dr. Richard C. Straube M.D., MSc. (1952) Senior Vice President & Chief Medical Officer | $294,510 |
Mr. Jonathan L. Guarino CPA, CGMA (1973) Senior Vice President, Chief Financial Officer & Corporation Sec. | $294,080 |
-
What's the price of Soligenix stock today?
One share of Soligenix stock can currently be purchased for approximately $3.68.
-
When is Soligenix's next earnings date?
Unfortunately, Soligenix's (SNGX) next earnings date is currently unknown.
-
Does Soligenix pay dividends?
No, Soligenix does not pay dividends.
-
How much money does Soligenix make?
Soligenix has a market capitalization of 7.27M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 11.55% to 839.36K US dollars.
-
What is Soligenix's stock symbol?
Soligenix, Inc. is traded on the NASDAQ under the ticker symbol "SNGX".
-
What is Soligenix's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Soligenix?
Shares of Soligenix can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Soligenix's key executives?
Soligenix's management team includes the following people:
- Dr. Christopher J. Schaber Ph.D. Chairman, Chief Executive Officer & Pres(age: 59, pay: $810,300)
- Dr. Oreola Donini Ph.D. Senior Vice President & Chief Scientific Officer(age: 53, pay: $380,460)
- Dr. Richard C. Straube M.D., MSc. Senior Vice President & Chief Medical Officer(age: 73, pay: $294,510)
- Mr. Jonathan L. Guarino CPA, CGMA Senior Vice President, Chief Financial Officer & Corporation Sec.(age: 52, pay: $294,080)
-
How many employees does Soligenix have?
As Jul 2024, Soligenix employs 13 workers.
-
When Soligenix went public?
Soligenix, Inc. is publicly traded company for more then 31 years since IPO on 4 Apr 1994.
-
What is Soligenix's official website?
The official website for Soligenix is soligenix.com.
-
Where are Soligenix's headquarters?
Soligenix is headquartered at 29 Emmons Drive, Princeton, NJ.
-
How can i contact Soligenix?
Soligenix's mailing address is 29 Emmons Drive, Princeton, NJ and company can be reached via phone at +60 9 538 8200.
Soligenix company profile:
Soligenix, Inc.
soligenix.comExchange:
NASDAQ
Full time employees:
13
Industry:
Biotechnology
Sector:
Healthcare
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has completed Phase III clinical trial for the treatment of treat cutaneous T-cell lymphoma; and SGX942, an innate defense regulator technology that is in Phase III clinical trial for the treatment of inflammatory diseases, including oral mucositis in head and neck cancer. This segment also offers proprietary formulations of oral beclomethasone 17,21-dipropionate for the prevention/treatment of gastrointestinal disorders characterized by severe inflammation, including SGX203 for pediatric Crohn's disease; and SGX302 that is in Phase I/II clinical trial for the treatment of mild-to-moderate psoriasis. The Public Health Solutions segment is involved in the development of RiVax, a ricin toxin vaccine candidate, which has completed Phase Ia and Ib clinical trials; SGX943, a therapeutic candidate that is in pre-clinical stage for the treatment of antibiotic resistant and emerging infectious diseases; ThermoVax, a technology in pre-clinical development for thermostabilizing vaccines; and CiVax, a vaccine candidate in pre-clinical development for the prevention of COVID-19. The company was formerly known as DOR BioPharma, Inc. and changed its name to Soligenix, Inc. in 2009. Soligenix, Inc. was incorporated in 1987 and is headquartered in Princeton, New Jersey.
29 Emmons Drive
Princeton, NJ 08540
Princeton, NJ 08540
CIK: 0000812796
ISIN: US8342235053
CUSIP: 834223307
